Bad Blood

The story unfolds through interviews, internal documents, fundraising pitches, and public records, delivering a story-led, evidence-based account that reads like a thriller while staying firmly grounded in fact. It traces how a beacon of innovation attracted billions in support, only to confront the hard realities of unproven technology, governance gaps, and mounting pressure from leadership and legal teams. The result is a transparent look at how big ambitions collide with real-world constraints.

For readers seeking practical insights, the book breaks down essential concepts such as due diligence, governance, investor dynamics, and regulatory scrutiny. It shows how skepticism and rigorous inquiry protect investors, patients, and markets, while offering accessible explanations of complex science and business decisions. The experience balances dramatic narrative with clear, learning-friendly analysis that demystifies high-stakes decision making.

• A detailed timeline of events from inception to consequences
• Profiles of key decision-makers, investors, and governance dynamics
• Clear exploration of fundraising strategies, product claims, and regulatory scrutiny
• Practical insights into due diligence, risk management, and ethical considerations
• Updated afterword with coverage of landmark trials and legal context
• Crips, precise investigative prose that guides readers through complex technology and business claims

Readers finish with a deeper understanding of how visionary ideas can falter without solid governance and transparent reporting. The book leaves you with sharpened analytical skills, heightened curiosity about how startups grow and fail, and a lasting appreciation for rigorous journalism that reveals truth in complex, high-stakes environments.